Views and analysis

Market access roundup: Government grillings for Vertex and US pharma

https://pharmaphorum.com/views-analysis-market-access/market-access-roundup-government-grillings-vertex-us-pharma-pricing/

Realising the potential of wearable tech

https://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/spire-health-clinical-trial-wearables/

The great regulatory catch-up

https://pharmaphorum.com/views-analysis-market-access/great-regulatory-medical-device/

The shadow of Brexit on speed of access

https://pharmaphorum.com/views-analysis-market-access/the-shadow-of-brexit-on-speed-of-access/

Eyeforpharma Barcelona 2019 roundup

https://pharmaphorum.com/digital/eyeforpharma-barcelona-2019-roundup/

Rethinking drug discovery

https://pharmaphorum.com/r-d/views-analysis-r-d/rethinking-drug-discovery/

Precision medicine: AZ’s Ruth March on its next steps

https://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/astrazeneca-ruth-march-precision-medicine/

R&D round-up: Non-opioid painkiller space heats up

https://pharmaphorum.com/views-and-analysis/rd-roundup-non-opioid-painkiller-space-heats-up/

Innovating in clinical trial recruitment

https://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/havas-lynx-faze-clinical-trials/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search